Curis, Inc. (CRIS) Announces FDA Acceptance and Priority Review of NDA for Vismodegib as Treatment for Advanced Basal Cell Carcinoma
11/9/2011 6:53:24 AM
More...
|
Dr. David Feigal Joins NDA Partners
10/19/2005 5:11:14 PM
More...
|
NDA Partners Guides Clinical Development For Biopharmaceutical And Medical Device Companies
10/19/2005 5:10:54 PM
More...
|